Thierry Naas
Université Paris-Sud(FR)Inserm(FR)Inserm(FR)Commissariat à l'Énergie Atomique et aux Énergies Alternatives(FR)Université Paris-Saclay(FR)Foundation for Human Potential(US)CEA Paris-Saclay - Etablissement de Fontenay-aux-roses(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)CEA Paris-Saclay(FR)Infectious Disease Models and Innovative Therapies(FR)CNR de la Résistance aux Antibiotiques(FR)Bicêtre Hospital(FR)Bicêtre Hospital(FR)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Antibiotics Pharmacokinetics and Efficacy, Bacterial biofilms and quorum sensing, Vibrio bacteria research studies
Most-Cited Works
- → Global Spread of Carbapenemase-producingEnterobacteriaceae(2011)2,275 cited
- → The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria(2009)1,576 cited
- → High Frequency Retrotransposition in Cultured Mammalian Cells(1996)1,030 cited
- → Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe(2012)878 cited
- → Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial(2020)746 cited
- → Beta-lactamase database (BLDB) – structure and function(2017)658 cited